Muuza offers AI‑powered, clinical‑grade health insights for women’s reproductive health—covering vaginal symptoms, period tracking, and pregnancy changes—delivered in minutes without the need for lab tests. The platform combines medical logic, image analysis, and real‑world symptom patterns, and is CE‑marked Class I, ensuring private, evidence‑based interpretations that help users make faster, informed decisions.
Funding
Funding not disclosed
Founders
Product
Problem
Women experiencing vaginal symptoms, menstrual irregularities, or early pregnancy signs often face delayed diagnosis because interpreting these signals requires lab tests, clinical visits, and specialist expertise. Overlapping symptoms lead many to guess or wait weeks for results, resulting in uncertainty and potential worsening of conditions.
Solution
Muuza offers a CE‑marked, privacy‑first digital platform that provides clinical‑grade reproductive health insights within minutes. Users submit symptom descriptions and, when applicable, images of vaginal discharge; the system applies structured medical logic, AI‑driven image analysis, and aggregated symptom patterns to generate evidence‑based interpretations for infections, menstrual changes, and pregnancy signals. Results are delivered instantly through a secure interface, eliminating the need for laboratory testing and reducing the typical waiting period. The platform maintains strict data confidentiality and continuously refines its models using anonymized user feedback, ensuring ongoing accuracy. By delivering objective health information quickly, Muuza helps women make informed decisions about over‑the‑counter treatments or seeking professional care.
Target Audience
Primary users are women seeking rapid, confidential interpretation of vaginal symptoms, menstrual irregularities, or early pregnancy signs, as well as telehealth providers and pharmacists who need quick, evidence‑based insights to support patient triage.
Features
- AI engine that combines medical decision trees, image analysis of discharge, and real‑world symptom data to produce diagnostic insights
- CE‑marked Class I medical device compliance under EU MDR, ensuring regulatory safety standards
- Immediate, lab‑free results delivered in under three minutes via a secure, encrypted web interface
- Privacy‑first architecture that anonymizes user data and stores it confidentially, with no personal identifiers retained
- Continuous model improvement through aggregated, anonymized feedback from a community of over 2,000 users
- Evidence‑based explanations of findings, including likely causes, recommended next steps, and guidance on when to seek clinical care